Yıl 2018, Cilt 6, Sayı 2, Sayfalar 36 - 44 2018-09-12

Erişkin İdiyopatik Trombositopenik Purpuralı Hastalarda IL-10 ve IL-17 Gen Polimorfizm
IL-10 and IL-17 Gene Polymorphisms in Adult Idiopathic Thrombocytopenic Purpura

Tuğba Songül TAT [1] , Mustafa YILMAZ [2] , Ahmet ALVER [3] , Gülşah BAYÇELEBİ [4]

3 7

Amaç: İnterlökin 10 (IL-10) ve interlökin 17 (IL-17) sitokin gen polimorfizmlerinin otoimmün birçok hastalıkta araştırıldığı ve bazılarında anlamlı sonuçlar bulunduğu ancak idiyopatik trombositopenik purpuralı (ITP) hastalarda IL-10 ve IL-17 gen polimorfizmleri ile ilgili yayınlanmış az sayıda çalışma mevcut olduğu görülmüştür. Bu çalışmada erişkin ITP hastalarında IL-10 (-592 A/C) ve IL-17 (A126G) gen polimorfizmi ve bu sitokinlerin serum düzeylerinin değerlendirilmesi amaçlanmıştır.

Materyal ve Metot: 50 ITP’ li hasta ve 51 sağlıklı kontrol grubunda IL-10 (-592 A/C) ve IL-17 (A126G) gen polimorfizmleri, DNA izolasyonu yapıldıktan sonra belirlenmiş ve bu sitokinlerin serum düzeyleri ELİSA yöntemi ile toplam 32 ITP’li hastada ve 32 sağlıklı kişide ölçülmüştür.

Bulgular: Hasta ve kontrol grupları arasında IL-10 (-592 A/C) ve IL-17 (A126G) gen polimorfizmleri dağılımı açısından istatistiksel olarak anlamlı fark bulunmazken, serum IL-10 düzeyleri ITP’li hastalarda sağlıklı bireylere göre istatistiksel olarak anlamlı derecede yüksek bulunmuştur (p=0,003). Serum IL-17 düzeyleri ise hasta ve kontrol grubunda benzer bulunmuştur. Ayrıca gruplar arasında yaş, cinsiyet, tedavi cevabı, tanı anıdaki trombosit değerleri karşılaştırılmış ancak gruplar arasında istatistiksel olarak anlamlı fark saptanmamıştır.

Sonuç: Çalışmamızda ITP’li hastalarda sağlıklı kişilere göre IL-10 (-592 A/C) ve IL-17 (A126G) gen polimorfizmleri sıklıklarının farklı olduğu saptanamasa da IL-10 düzeyleri ITP’li grupta yüksek bulunmuştur. Sitokinlerin ITP’nin tanı ve takibindeki önemini açıklığa kavuşturabilmek için literatürdeki veriler de dikkate alındığında bu alanda daha geniş hasta serili çalışmalara ihtiyaç olduğunu düşünmekteyiz

Objective: Interleukin 10 (IL-10) and interleukin 17 (il-17) cytokine gene polymorphisms were investigated in many autoimmune diseases and there were significant results in some studies but there were a few published studies on IL-10 and il-17 gene polymorphisms in idiopathic thrombocytopenic purpura ( ITP). In this study, we aimed to evaluate the IL-10 (-592 A/C) and IL-17 (A126G) gene polymorphisms and their serum levels in adult patients with ITP.

Materials and Methods: The IL-10 (-592 A/C) and IL-17 (A126G) gene polymorphisms in 50 patients with ITP and 51 healthy control groups were determined after DNA isolation and serum levels of these cytokines were measured by ELISA method in 32 patients with ITP and 32 healthy volunteers.

Results: There was no statistically significant difference in IL-10 (-592 A/C) and IL-17 (A126G) gene polymorphisms between the patients and control groups, whereas serum IL-10 levels were found to be statistically significant higher in ITP patients than control group (p=0.003). Serum IL-17 levels were similar in patients and control groups. In addition, age, sex, response to treatment and platelet values at diagnosis were compared between the groups, but there was no statistically significant difference between the groups.

Conclusion: In our study, IL-10 (-592 A/C) and IL-17 (A126G) gene polymorphisms were not found to be different in patients with ITP compared to healthy subjects, although IL-10 levels were found to be higher in the ITP group than healthy group. When we look the datas in the literature, we think that more studies with larger series are needed in this field in order to clarify the importance of cytokines in the diagnosis and follow-up of ITP.

  • 1. Lambert MP, Gernsheimer TB. Clinical updates in adult immune thrombocytopenia. Blood. 2017; 129(21):2829–35.
  • 2. Semple J.W., Provan D. The immunopathogenesis of immune thrombocytopenia: T cells still take center-stage Curr Opinion Hematol. 2012;19:357-62
  • 3. Raphael I, Nalawade S, Eagar TN, Forsthuber TG. T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. Cytokine. 2015;74:5-17.
  • 4. Wang T, Zhao H, Ren H, Guo J, Xu M, Yang R, et al. Type 1 and type 2 T-cell profiles in idiopathic thrombocytopenic purpura. Haematologica. 2005;90:914-23.
  • 5. Ogawara H, Handa H, Morita K, Hayakawa M, Kojima J, Amagai H, et al. High Th1/ Th2 ratio in patients with chronic idiopathic thrombocytopenic purpura. Eur J Haematol. 2003;71:283-8.
  • 6. Rocha AM, Souza C, Rocha GA, de Melo FF, Clementino NC, Marino MC, et al. The levels of IL-17A and of the cytokines involved in Th17 cell commitment are increased in patients with chronic immune thrombocytopenia. Haematologica. 2011;96:1560-4.
  • 7. ZhouL,XuF,ChangC,TaoY,SongL,LiX. Interleukin-17-producing CD4+T lymphocytes are increased in the patients with primary immune thrombocytopenia. Blood Coagul Fibrinolysis. 2016;27:301-7.
  • 8. Mosser DM, Zhang X. Interleukin-10: new perspectives on an old cytokine. Immunol Rev. 2008;226:205-18
  • 9. Zhang G, Zhang P, Liu H, Liu X, Xie S, Wang X, et al. Assessment of Th17/Treg cells and Th cytokines in an improved immune thrombocytopenia mouse model. Hematology. 2017;22:493-500.
  • 10. Rezaeeyan H, Jaseb K, Alghasi A, Asnafi AA, Saki N. Association between gene polymorphisms and clinical features in idiopathic thrombocytopenic purpura patients. Blood Coagul Fibrinolysis 2017;28:617-22.
  • 11. Pehlivan M, Okan V, Sever T, Balci SO, Yilmaz M, Babacan T, et al. Investigation of TNF-alpha, TGF-beta 1, IL-10, IL-6, IFN-gamma, MBL, GPIA, and IL1A gene polymorphisms in patients with idiopathic thrombocytopenic purpura. Platelets. 2011;22(8):588-95.
  • 12. Saitoh T, Kasamatsu T, Inoue M, Mitsui T, Koiso H, Yokohama A, et al. Interleukin-10 gene polymorphism reflects the severity of chronic immune thrombocytopenia in Japanese patients. Int J Lab Hematol. 2011;33:526-32.
  • 13. Wu KH, Peng CT, Li TC, Wan L, Tsai CH, Lan SJ, Chang MC, Tsai FJ. Interleukin 4, interleukin 6 and interleukin 10 polymorphisms in children with acute and chronic immune thrombocytopenic purpura. Br J Haematol. 2005;128(6):849-52.
  • 14. Khalilzadeh O, Anvari M, Momen-Heravi F, Esteghamati A, Rashidi A, Mahmoudi M, et al. Gene polymorphisms of interleukin-4, interleukin-10 and transforming growth factor-beta in Graves’ disease. Clin Exp Med. 2010;10(2):123–8.
  • 15. Gambhir D, Lawrence A, Aggarwal A, Misra R, Mandal SK, Naik S. Association of tumor necrosis factor alpha and IL-10 promoter polymorphisms with rheumatoid arthritis in North Indian population. Rheumatol Int. 2010; 30(9):1211–7.
  • 16. Jang WC, Nam YH, Ahn YC, Lee SH, Park SH, Choe JY, et al. Interleukin-17F gene polymorphisms in Korean patients with Behçet's disease. Rheumatol Int. 2008;29:173-8.
  • 17. Ma D, Zhu X, Zhao P, Zhao C, Li X, Zhu Y, et al. Profile of Th17 cytokines (IL-17, TGFbeta, IL-6) and Th1 cytokine (IFN-gamma) in patients with immune thrombocytopenic purpura. Ann Hematol 2008;87:899-904.
  • 18. Ji L, Zhan Y, Hua F, Li F, Zou S, Wang W, et al. The ratio of treg/th17 cells correlates with the disease activity of primary immune thrombocytopenia. PLoS One. 2012; 7:e50909.
  • 19. Hu Y, Ma DX, Shan NN, Zhu YY, Liu XG, Zhang L, et al. Increased number of Tc17 and correlation with Th17 cells in patients with immune thrombocytopenia. PLoS One. 2011;6:e26522.
  • 20. Zhang J, Ma D, Zhu X, Qu X, Ji C, Hou M. Elevated profile of Th17, Th1 and Tc1 cells in patients with immune thrombocytopenic purpura. Haematologica. 2009;94:1326-9.
  • 21. Li F, Ji L, Wang W, Hua F, Zhan Y, Zou S, et al. Insufficient secretion of IL-10 by Tregs compromised its control on over-activated CD4+ T effector cells in newly diagnosed adult immune thrombocytopenia patients. Immunol Res. 2015;61:269-80.
  • 22. Liu B, Zhao H, Poon MC, Han Z, Gu D, Xu M, et al. Abnormality of CD4(+)CD25(+) regulatory T cells in idiopathic thrombocytopenic purpura. Eur J Haematol. 2007; 78:139-43.
  • 23. Tesse R, Del Vecchio GC, De Mattia D, Sangerardi M, Valente F, Giordano P. Association of interleukin-(IL)10 haplotypes and serum IL-10 levels in the progression of childhood immune thrombocytopenic purpura. Gene. 2012;505:53-6.
  • 24. Saitoh T, Tsukamoto N, Koiso H, Mitsui T, Yokohama A, Handa H, et al. Interleukin-17F gene polymorphism in patients with chronic immune thrombocytopenia. Eur J Haematol. 2011;87(3);253-8.
  • 25. Culic S, Labar B, Marusic A, Salamunic I. Correlations among age, cytokines, lymphocyte subtypes, and platelet counts in autoimmune thrombocytopenic purpura. Pediatr Blood Cancer. 2006; 47:671-4.
  • 26. Wang JD, Chang TK, Lin HK, Huang FL, Wang CJ, Lee HJ. Reduced expression of transforming growth factor‐β1 and correlated elevation of interleukin‐17 and interferon‐γ in pediatric patients with chronic primary immune thrombocytopenia (ITP). Pediatr Blood Cancer. 2011;57:636-40.
  • 27. Guo NH, Shi QZ, Hua JY, Li ZJ, Li J, He WF, et al. Expression of regulatory T cells and Th17 cells in idiopathic thrombocytopenic purpura and its significance. Zhonghua Xue Ye Xue Za Zhi. 2010;31(9):610-12.
  • 28. Chang DY, Ouyang J, Zhou RF, Xu JY, Chen B, Yang YG, Zhang QG, Shao XY, Guan CY, Xu Y: Profiles of different subsets of CD(4)(+) T cells in chronic idiopathic thrombocytopenic purpura. Zhonghua Nei Ke Za Zhi. 2010;49(3):213-6.
  • 29. Wang X, Zhou YH, Chen XH, Yin LM, Zhao YN, Wo, LK, et al. Role and Significance of T Help Cells 17 in Pathogenesis of Idiopathic Thrombocytopenic Purpura. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016; 24(6):1833-36.
  • 30. Qiao J, Li X, Wu Y, Wu X, Zhu F, Liu N, et al. An increased expression profile of Th9/IL-9 correlated with Th17/IL-17 in patients with immune thrombocytopenia. Platelets. 2017;28(3);287-94.
Birincil Dil tr
Konular Tıp Bilimleri
Dergi Bölümü Araştırma Makalesi
Yazarlar

Orcid: 0000-0001-6752-320X
Yazar: Tuğba Songül TAT (Sorumlu Yazar)
Kurum: Dr. Ersin Arslan Eğitim ve Araştırma Hastanesi, Allerji-İmmünoloji Birimi, Gaziantep, Türkiye
Ülke: Turkey


Yazar: Mustafa YILMAZ
Kurum: Karadeniz Teknik Üniversitesi Tıp Fakültesi,İç hastalıkları ABD, Hematoloji BD, Trabzon
Ülke: Turkey


Yazar: Ahmet ALVER
Kurum: Karadeniz Teknik Üniversitesi Tıp Fakültesi, Tıbbi Biyokimya ABD, Trabzon
Ülke: Turkey


Yazar: Gülşah BAYÇELEBİ
Kurum: Serbest Hekim, İç hastalıkları, Samsun
Ülke: Turkey


Bibtex @araştırma makalesi { nkmj420191, journal = {Namık Kemal Tıp Dergisi}, issn = {}, address = {Namık Kemal Üniversitesi}, year = {2018}, volume = {6}, pages = {36 - 44}, doi = {}, title = {Erişkin İdiyopatik Trombositopenik Purpuralı Hastalarda IL-10 ve IL-17 Gen Polimorfizm}, key = {cite}, author = {TAT, Tuğba Songül and YILMAZ, Mustafa and BAYÇELEBİ, Gülşah and ALVER, Ahmet} }
APA TAT, T , YILMAZ, M , ALVER, A , BAYÇELEBİ, G . (2018). Erişkin İdiyopatik Trombositopenik Purpuralı Hastalarda IL-10 ve IL-17 Gen Polimorfizm. Namık Kemal Tıp Dergisi, 6 (2), 36-44. Retrieved from http://dergipark.gov.tr/nkmj/issue/39120/420191
MLA TAT, T , YILMAZ, M , ALVER, A , BAYÇELEBİ, G . "Erişkin İdiyopatik Trombositopenik Purpuralı Hastalarda IL-10 ve IL-17 Gen Polimorfizm". Namık Kemal Tıp Dergisi 6 (2018): 36-44 <http://dergipark.gov.tr/nkmj/issue/39120/420191>
Chicago TAT, T , YILMAZ, M , ALVER, A , BAYÇELEBİ, G . "Erişkin İdiyopatik Trombositopenik Purpuralı Hastalarda IL-10 ve IL-17 Gen Polimorfizm". Namık Kemal Tıp Dergisi 6 (2018): 36-44
RIS TY - JOUR T1 - Erişkin İdiyopatik Trombositopenik Purpuralı Hastalarda IL-10 ve IL-17 Gen Polimorfizm AU - Tuğba Songül TAT , Mustafa YILMAZ , Ahmet ALVER , Gülşah BAYÇELEBİ Y1 - 2018 PY - 2018 N1 - DO - T2 - Namık Kemal Tıp Dergisi JF - Journal JO - JOR SP - 36 EP - 44 VL - 6 IS - 2 SN - - M3 - UR - Y2 - 2018 ER -
EndNote %0 Namık Kemal Tıp Dergisi Erişkin İdiyopatik Trombositopenik Purpuralı Hastalarda IL-10 ve IL-17 Gen Polimorfizm %A Tuğba Songül TAT , Mustafa YILMAZ , Ahmet ALVER , Gülşah BAYÇELEBİ %T Erişkin İdiyopatik Trombositopenik Purpuralı Hastalarda IL-10 ve IL-17 Gen Polimorfizm %D 2018 %J Namık Kemal Tıp Dergisi %P - %V 6 %N 2 %R %U
ISNAD TAT, Tuğba Songül , YILMAZ, Mustafa , ALVER, Ahmet , BAYÇELEBİ, Gülşah . "Erişkin İdiyopatik Trombositopenik Purpuralı Hastalarda IL-10 ve IL-17 Gen Polimorfizm". Namık Kemal Tıp Dergisi 6 / 2 (Eylül 2018): 36-44.